|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Ikarian Capital LLC
✚
|
|
|---|---|
| CRD # | 281880 |
| SEC # | 801-118894 |
| CIK # | 0001778253 |
| AUM | $559.8 M (2025-03-28) |
| Employees | 6 (50% Investors, 0% Brokers) |
| Phone | 214-276-0670 |
| Address | 100 Crescent Court Dallas, TX 75201 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001778253 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Cidara Therapeutics Inc | 0.1 | ||
| Capnia Inc | 0.0 | ||
| Ultragenyx Pharmaceutical Inc | 0.0 | ||
| Praxis Precision Medicines Inc | 0.0 | ||
| Nile Therapeutics Inc | 0.0 | ||
| Alnylam Pharmaceuticals Inc | 0.0 | ||
| Insmed Inc | 0.0 | ||
| Akero Therapeutics Inc | 0.0 | ||
| Verona Pharma PLC | 0.0 | ||
| Apogee Therapeutics Inc | 0.0 | ||
| Helix Acquisition Corp | 0.0 | ||
| Avi Biopharma Inc | 0.0 | ||
| Cytokinetics Inc | 0.0 | ||
| Crinetics Pharmaceuticals Inc | 0.0 | ||
| Viking Therapeutics Inc | 0.0 | ||
| Vaxcyte Inc | 0.0 | ||
| UNUM Therapeutics Inc | 0.0 | ||
| Alpha Cognition Inc | 0.0 | ||
| Tarsus Pharmaceuticals Inc | 0.0 | ||
| Manhattan Pharmaceuticals Inc | 0.0 | ||
| Carbylan Therapeutics Inc | 0.0 | ||
| Fulcrum Therapeutics Inc | 0.0 | ||
| Signal Genetics Inc | 0.0 | ||
| Arvinas Inc | 0.0 | ||
| Tocagen Inc | 0.0 | ||
| VIR Biotechnology Inc | 0.0 | ||
| Scholar Rock Holding Corp | 0.0 | ||
| Silence Therapeutics PLC | 0.0 | ||
| Catalyst Pharmaceutical Partners Inc | 0.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Ikarian Healthcare Master Fund LP | [2020-05-12] | 256.6 | 445.1 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 559.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 559.8 |
| By Discretionary | ||
| Discretionary | 5 | 559.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 559.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 473.7 | |
| United States Persons | 86.1 | |
| Total | 5 | 559.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Neil Shahrestani | 2 | ||
| Chart Westcott | 2 | ||
| Ikarian Capital LLC | 2 | ||
| Chart Westcott Living Trust | 2 | ||
| Ikarian Healthcare Fund GP LP | 1 | ||
| Ikarian Healthcare LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001778253] | |
| 3 | [0001778253] | |
| 4 | [0001778253] | |
| SC 13G | [0001778253] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Ikarian Healthcare Fund GP, L.P. | |
| Ikarian Capital, LLC | |
| Tracon Pharmaceuticals, Inc. | |
| Ikarian Healthcare Master Fund, L.P. | |
| Shahrestani Neil | |
| Chart Westcott Living Trust |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Western Standard LLC
✚
|
CA | 0.6 |
|
Stieven Capital Advisors LP
✚
|
MO | 0.6 |
|
Alta Fox Capital Management LLC
✚
|
TX | 0.6 |
|
Borealis Strategic Capital Partners LP
✚
|
IL | 0.6 |
|
Alight Capital Management LP
✚
|
NY | 0.6 |
|
Sarissa Capital Management LP
✚
|
CT | 0.6 |
|
Stanley Capital Management LLC
✚
|
TX | 0.6 |
|
Diametric Capital LP
✚
|
MA | 0.6 |
|
NAVI Intl-Administradora E Gestora de Recursos Financeiros LTDA
✚
|
0.6 | |
|
Collab Currency Management LLC
✚
|
0.6 |